Standardization of reporting obstructive airway disease in children: A national Delphi process

Elsevier

Available online 13 September 2022

The Journal of Allergy and Clinical Immunology: In PracticeAbstractBackground

Pediatric pulmonologists report asthma and obstructive bronchitis in medical records in a variety of ways and there is no consensus for standardized reporting.

Objective

We investigated which diagnostic labels and features pediatric pulmonologists use to describe obstructive airway disease in children and aimed to reach consensus for standardized reporting.

Methods

We obtained electronic health records from 562 children participating in the Swiss Pediatric Airway Cohort (SPAC) from 2017 to 2018. We reviewed the diagnosis section of the letters written by pediatric pulmonologists to referring physicians and extracted the terms used to describe the diagnosis. We grouped these terms into diagnostic labels (e.g., asthma) and features (e.g., triggers) using qualitative thematic framework analysis. We also assessed how frequently the different terms were used. Results were fed into a modified Delphi process to reach consensus on standardized reporting.

Results

Pediatric pulmonologists used 123 different terms to describe the diagnosis, which we grouped into 6 diagnostic labels and 17 features. Consensus from the Delphi process resulted in the following recommendations: (i) to use the diagnostic label ”asthma” for children older than 5 years and ”obstructive bronchitis” or ”suspected asthma” for children younger than 5 years; (ii) to accompany the diagnosis with relevant features: diagnostic certainty, triggers, symptom control, risk of exacerbation, atopy, treatment adherence, and symptom perception.

Conclusion

We found great heterogeneity in the reporting of obstructive airway disease among pediatric pulmonologists. The proposed standardized reporting will simplify communication among physicians and improve quality of research based on electronic health records.

View full text

© 2022 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology

留言 (0)

沒有登入
gif